RxDoctor Payments Data

Rebekah Simmons, APRN

Family · Phenix City, ALNPI 1811408818

Payments from drug & device makers

$631in general payments, 2019–2025

Across 38 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$158
  • AstraZeneca$98
  • AbbVie$94
  • Mylan Specialty L.p.$73
  • Pfizer$61
  • Viatris Specialty LLC$57
  • plus $90 from 3 others

What the payments were for

  • Food & beverage$631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$631 in reported general payments places this provider in the 55th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$43,715
Medicare patients
214
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$67,260
EliquisApixaban50$45,116
JardianceEmpagliflozin13$23,397
XareltoRivaroxaban14$23,218
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$15,953
JanuviaSitagliptin Phosphate12$15,797
MounjaroTirzepatide11$11,564
EntrestoSacubitril/Valsartan11$8,912
Albuterol Sulfate HfaAlbuterol Sulfate137$4,427
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,942
Omeprazole163$2,452
Diclofenac Sodium71$2,131
Atorvastatin Calcium271$2,034
Nano 2nd Gen Pen NeedlePen Needle, Diabetic17$1,792
Potassium Chloride91$1,615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$41$67,26062 claims
PfizerEliquis$61$45,11650 claims
Lilly USA, LLCMounjaro$158$11,56411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,415 family providers in Alabama.

Other family in Phenix City

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →